Skip to content

LanzaTech Global, Inc. LNZA Compensation and benefits

Compensation and benefits at other companies

Honeywell International logo
Honeywell InternationalHON
KBR logo
KBRKBR
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-75.8%
Enterprise value$72.09M-75.1%
P/S1.3×-6.4×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%
Debt / equity0.3×
Current ratio-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LanzaTech Global, Inc.'s compensation and benefits?
LanzaTech Global, Inc. (LNZA) reported compensation and benefits of $1.73M in Q1 2026.
How has LanzaTech Global, Inc.'s compensation and benefits changed year-over-year?
LanzaTech Global, Inc.'s compensation and benefits decreased by 29.3% year-over-year, from $2.45M to $1.73M.
What is the long-term trend for LanzaTech Global, Inc.'s compensation and benefits?
Over 3 years (2022 to 2025), LanzaTech Global, Inc.'s compensation and benefits has grown at a -36.0% compound annual growth rate (CAGR), from $7.03M to $1.84M.